Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for ALGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 192.76M
March 31, 2026 151.04M
December 31, 2025 223.18M
September 30, 2025 188.72M
June 30, 2025 128.65M
March 31, 2025 52.68M
December 31, 2024 286.08M
September 30, 2024 263.66M
June 30, 2024 159.83M
March 31, 2024 28.66M
December 31, 2023 46.90M
September 30, 2023 287.21M
June 30, 2023 251.78M
March 31, 2023 199.90M
December 31, 2022 144.71M
September 30, 2022 266.48M
June 30, 2022 127.04M
March 31, 2022 30.50M
December 31, 2021 272.85M
September 30, 2021 355.00M
June 30, 2021 317.50M
March 31, 2021 227.19M
December 31, 2020 381.42M
September 30, 2020 211.07M
June 30, 2020 59.90M
Date Value
March 31, 2020 9.784M
December 31, 2019 218.18M
September 30, 2019 234.53M
June 30, 2019 177.35M
March 31, 2019 117.21M
December 31, 2018 241.30M
September 30, 2018 96.26M
June 30, 2018 139.79M
March 31, 2018 77.33M
December 31, 2017 162.33M
September 30, 2017 118.12M
June 30, 2017 110.47M
March 31, 2017 47.62M
December 31, 2016 80.98M
September 30, 2016 59.83M
June 30, 2016 76.17M
March 31, 2016 30.68M
December 31, 2015 79.36M
September 30, 2015 60.06M
June 30, 2015 62.94M
March 31, 2015 35.64M
December 31, 2014 71.60M
September 30, 2014 67.57M
June 30, 2014 69.73M
March 31, 2014 17.99M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Dentsply Sirona, Inc. 99.00M
Integra LifeSciences Holdings Corp. 22.80M
Envista Holdings Corp. 119.20M
Intuitive Surgical, Inc. 1.061B
Boston Scientific Corp. 1.474B